TITLE

The effectiveness and efficiency of diabetes screening in Ontario, Canada: a population-based cohort study

AUTHOR(S)
Wilson, Sarah E.; Rosella, Laura C.; Lipscombe, Lorraine L.; Manuel, Douglas G.
PUB. DATE
January 2010
SOURCE
BMC Public Health;2010, Vol. 10 Issue 1, p506
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Little is known about the efficiency and effectiveness of the current level of diabetes screening activity in Ontario where there is universal access to health services. Our study aims were to: (i) determine how often Ontarians are screened for diabetes; (ii) estimate screening efficiency based on the number needed to screen (NNS) to diagnosis one diabetes case; (iii) examine the population effectiveness of screening as estimated by the number of undiagnosed diabetes cases. Methods: Ontario respondents of the Canadian Community Health Survey who agreed to have their responses linked to health care data (n = 37,400) provided the cohort. The five-year probabilities of glucose testing and diabetes diagnoses were estimated using a Cox Proportional Hazards Model. We defined NNS as the ratio of diabetes tests to number of diabetes diagnoses over the study period. We estimated the number of undiagnosed diabetes by dividing the number not tested at the end of study period by the NNS. Results: 80% of women and 66% of men had a blood glucose test within 5 years. The efficiency of screening was estimated by a NNS of 14 among men and 22 among women. 127,100 cases of undiagnosed diabetes were estimated, representing 1.4% of the Ontario adult population. Increasing age, hypertension, immigrant and nonwhite ethnicity, and number of general practitioner visits were associated with an increased likelihood of having a glucose test (LR χ2 p < 0.001). Low income men were less likely to be tested. Conclusions: Diabetes screening was high in this population-based cohort of Ontarians. Screening efficiency varied considerably in the population. Undiagnosed diabetes continues to be prevalent and remains concentrated in the highest risk groups for diabetes, especially among men.
ACCESSION #
54098801

 

Related Articles

  • WHY NOT USE GLYCOSYLATED HEMOGLOBIN TO SCREEN FOR DIABETES? Point, Cynthia A. // Cortlandt Forum;5/25/2004, Vol. 17 Issue 5, p71 

    Focuses on the reasons for the exception of routine diabetic screening in California. Value of the fasting glucose criterion for diabetes; Importance of the standardization; Reason for the exception of the screening.

  • WHY NOT USE GLYCOSYLATED HEMOGLOBIN TO SCREEN FOR DIABETES? Kernan, Walter N. // Cortlandt Forum;5/25/2004, Vol. 17 Issue 5, p71 

    Focuses on the reasons for the exception of routine diabetic screening in California. Value of the fasting glucose criterion for diabetes; Importance of the standardization; Reason for the exception of the screening.

  • 16-year excess all-cause mortality of newly diagnosed type 2 diabetic patients: a cohort study. Hansen, Lars J.; de Fine Olivarius, Niels; Siersma, Volkert // BMC Public Health;2009, Vol. 9 Issue 1, p400 

    Background: Studies have shown that type 2 diabetic patients have higher all-cause mortality than people without diabetes, but it is less clear how diabetes affects mortality in elderly patients and to what degree mortality differs between diabetic men and women. The aim of the present study is...

  • Glucose testing and insufficient follow-up of abnormal results: a cohort study. Kern, Lisa M.; Callahan, Mark A.; Brillon, David J.; Vargas, Maryelena; Mushlin, Alvin I. // BMC Health Services Research;2006, Vol. 6, p87 

    Background: More than 6 million Americans have undiagnosed diabetes. Several national organizations endorse screening for diabetes by physicians, but actual practice is poorly understood. Our objectives were to measure the rate, the predictors and the results of glucose testing in primary care,...

  • Changes in Renal Function Associated with Tenofovir Disoproxil Fumarate Treatment, Compared with Nucleoside Reverse-Transcriptase Inhibitor Treatment. Gallant, Joel E.; Parish, Michelle A.; Keruly, Jeanne C.; Moore, Richard D. // Clinical Infectious Diseases;4/15/2005, Vol. 40 Issue 8, p1194 

    In our large observational cohort, use of tenofovir disoproxil fumarate (n = 344) was associated with a greater decline in renal function than was use of alternative nucleoside analogues (n = 314). Other associations included a lower CD4 cell count, decreased renal function at baseline, and...

  • Increasing Incidence and Age at Diagnosis among Children with Type 1 Diabetes Mellitus over a 20-Year Period in Auckland (New Zealand). Derraik, Jos� G. B.; Reed, Peter W.; Jefferies, Craig; Cutfield, Samuel W.; Hofman, Paul L.; Cutfield, Wayne S. // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Background: We aimed to evaluate the incidence of type 1 diabetes mellitus in children <15 years of age (yr) in the Auckland region (New Zealand) over 20 years (1990-2009). Methods: We performed a retrospective review of all patients <15 yr diagnosed with type 1 diabetes, from an unselected...

  • BENEFITS OF THREE-MONTH CONTINUOUS GLUCOSE MONITORING FOR PERSONS WITH DIABETES USING INSULIN PUMPS AND SENSORS. Peterson, Karolina; Zapletalova, Jana; Kudlova, Pavla; Matuskova, Veronika; Bartek, Josef; Novotny, Dalibor; Chlupa, Rudolf // Biomedical Papers of the Medical Faculty of Palacky University i;2009, Vol. 153 Issue 1, p47 

    Background: The latest Paradigm 722 insulin pump, Medtronic MiniMed, USA, enables daily reading of 288 interstitial fluid glucose concentrations determined by a sensor inserted into subcutaneous tissue; the sensor signals are transmitted into the insulin pump, enabling the patient to see...

  • Increasing Incidence and Age at Diagnosis among Children with Type 1 Diabetes Mellitus over a 20-Year Period in Auckland (New Zealand). Derraik, José G. B.; Reed, Peter W.; Jefferies, Craig; Cutfield, Samuel W.; Hofman, Paul L.; Cutfield, Wayne S. // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Background: We aimed to evaluate the incidence of type 1 diabetes mellitus in children <15 years of age (yr) in the Auckland region (New Zealand) over 20 years (1990-2009). Methods: We performed a retrospective review of all patients <15 yr diagnosed with type 1 diabetes, from an unselected...

  • Pupil cycle time and contrast sensitivity in type II diabetes mellitus patients: A pilot study. Hoyoung Lee; Youngkook Kim; Jongseok Park // Indian Journal of Ophthalmology;May2011, Vol. 59 Issue 3, p201 

    Context: Pupil cycle time (PCT) has been widely used for examination of ocular diabetic autonomic neuropathy (DAN). Aims: The primary aim of this study was to evaluate the difference of contrast sensitivity according to PCT results, and the secondary aim was to determine the factors associated...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics